Vulvar porokeratosis: Case report and review of the literature

International Journal of Gynecological Pathology

Volumn 18, Issue 2, 1999, Pages 169-173

  Robinson, Jubilee B ^a   Im, Dwight D ^a   Jockle, Glenn ^a   Rosenshein, Neil B ^a  

^a MERCY MEDICAL CENTER   (United States)

Author keywords

Comoid lamella; Porokeratosis; Ultrasonic aspiration; Vulva

Indexed keywords

ADULT; ARTICLE; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POROKERATOSIS; PRIORITY JOURNAL; PRURITUS; VULVA DISEASE;

EID: 0033066803     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199904000-00012     Document Type: Article

References (34)

1. Happle R. Cancer proneness of linear porokeratosis may be explained by allelic loss. Dermatology 1997;195:20-5.
2. Gautam RK, Bedi GK, Sehgal VN, Singh N. Simultaneous occurrence of disseminated superficial actinic porokeratosis (DSAP), linear, and punctate porokeratosis. Int J Dermatol 1995;34:71-2.
3. Yasuda K, Ikeda M, Ikeda M, Kodama H. Disseminated superficial porokeratosis with amyloid deposition. J Dermatol 1996;23: 111-5.
4. Handa S, Dawn G, Kumar B. Mutilating lesions in porokeratosis of Mibelli. Dermatology 1995;191:62-4.
5. Schamroth JM, Zlotogorski A, Gilead L. Porokeratosis of Mibelli. Acta Derm Venereal (Stockh) 1997;77:207-13.
6. Otsuka F, Iwata M, Watanabe R, Chi HI, Ishibashi Y. Porokeratosis: clinical and cellular characterization of its cancer-prone nature. J Dermatol 1992;19:702-6.
7. Zenarola P, Melillo L, Lomuto M, Carotenuto M, Gomes VE, Marzocchi W. Exacerbation of porokeratosis: a sign of immunodepression. J Am Acad Dermatol 1993;29:1035-6.
8. Jacyk WK, Esplin L. Hyperkeratotic form of porokeratosis of Mibelli. Int J Dermatol 1993;32:902-3.
9. Lucker GPH, Happle R, Steijlen PM. An unusual case of porokeratosis involving the natal cleft: porokeratosis ptychotropica? Br J Dermatol 1995;132:150-1.
10. Neri I, Marzaduri S, Passarini B, Patrizi A. Genital porokeratosis of Mibelli. Genitourin Med 1995;71:410-1.
11. Levell NJ, Bewley AP, Levene GM. Porokeratosis of Mibelli of the penis, scrotum, and natal cleft. Clin Exp Dermatol 1994;19: 77-8.
12. Tangoren IA, Weinberg JM, Ioffreda M, Werth VP, James WD. Penile porokeratosis of Mibelli. J Am Acad Dermatol 1997;36: 479-81.
13. Mibelli V. Contribute allo studio della ipercheratosi dei canali sudoriferi. Gior Ital d Mal Ven 1893;28:313-55.
14. Respighi E. Di una ipercheratosi non anchora descritta. Gior Ital d Mal Yen 1893;23:356-86.
15. Andrews GC. Porokeratosis (Mibelli) disseminated and superficial type. Arch Dermatol Syphilol 1937;36:1111.
16. McCullough TL, Lesher JL, Jr. Porokeratosis of Mibelli: rapid recurrence of a large lesion after carbon dioxide laser treatment. Pediatr Dermatol 1994;11:267-70.
17. Sehgal VN, Jain S, Singh N. Porokeratosis. J Dermatol 1996;23: 517-25.
18. Schaller M, Korting HC, Kollmann M, Kind P. The hyperkeratotic variant of Porokeratosis Mibelli is a distinct entity: clinical and ultrastructural evidence. Dermatology 1996;192:255-8.
19. Scappaticci S, Lambiase G, Orrechia G, Fraccaro M. Clonal chromosome abnormalities with preferential involvement of chromosome 3 in patients with porokeratosis of Mibelli. Cancer Genet Cytogenet 1989;43:89-94.
20. Herranz P, Pizarro A, DeLucas R, et al. High incidence of porokeratosis in renal transplant recipients. Br J Dermatol 1997;136: 176-9.
21. Reed RJ, Leone P. Porokeratosis - A mutant clonal keratosis of the epidermis. Arch Dermatol 1970;101:310-7.
22. Lederman JS, Sober AJ, Lederman GS. Immunosuppression: a cause of porokeratosis. J Am Acad Dermatol 1985;13:75-9.
23. Taniguchi Y, Yuasa T, Shimizu M. Linear porokeratosis. J Dermatol 1993;20:489-92.
24. Lozinski AZ, Fisher BK, Walter JB, Fitzpatrick PJ. Metastatic squamous cell carcinoma in linear porokeratosis of Mibelli. J Am Acad Dermatol 1987;16:448-51.
25. Otsuka F, Someya T, Ishibashi Y. Porokeratosis and malignant skin tumors. J Cancer Res Clin Oncol 1991;117:55-60.
26. Chernosky ME, Rapini RP. Squamous cell carcinoma in lesions of disseminated superficial actinic porokeratosis: a report of two cases. Arch Dermatol 1986;122:853-5.
27. Gray MH, Smoller BS, McNutt NS. Carcinogenesis in porokeratosis: evidence for a role relating to chronic growth activation of keratinocytes. Am J Dermatopathol 1991;13:438-44.
28. Magee JW, McCalmont TH, LeBoit PE. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol 1994; 130:187-90.
29. Puig L, Alegre M, Costa I, Matias-Guiu X, deMoragas JM. Overexpression of p53 in disseminated superficial actinic porokeratosis with and without malignant degeneration. Arch Dermatol 1995; 131:353-4.
30. Urano Y, Sasaki S, Ninomiya Y, Dura H, Arase S. Immunohistochemical detection of p53 tumor suppressor protein in porokeratosis. J Dermatol 1996;23:365-8.
31. Ninomiya Y, Urano Y, Yoshimoto K, Iwahana H, Sasaki S, Arase S, Itakura M. p53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma. J Dermatol Sci 1997;14:173-8.
32. McNutt NS, Saenz-Santamaria C, Volkenandt M, Shea CR, Albino AP. Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol 1994;130:225-32.
33. Goldman GD, Milstone LM. Generalized linear porokeratosis treated with etretinate. Arch Dennatol 1995;131:496-7.
34. Tsamboas D, Spiliopoulos T. Disseminated superficial porokeratosis: complete remission subsequent to discontinuation of immunosuppression. J Am Acad Dermatol 1993;28:651-2.